SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-128617
Filing Date
2021-10-21
Accepted
2021-10-21 20:39:43
Documents
2
Period of Report
2021-10-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2130646-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2130646-2_3seq1.xml 3 4164
2 EXHIBIT 24.1 tm2130646d2_ex24-1.htm EX-24.1 7274
  Complete submission text file 0001104659-21-128617.txt   12647
Mailing Address
Business Address
LYNCH DANIEL (Reporting) CIK: 0001177082 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 211338415

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations